ATLASATLAS fair value
ATLAS has no fair value for this stock today.
Acutaas Chemicals (AMIORG.NSE)
Acutaas Chemicals share price today, ATLAS forecast and fair value
Basic Materials · Specialty Chemicals · National Stock Exchange of India · India
₹3,349▲ +6.73%
Prices as of Oct 26, 2026 · INR
Chance of rising in 1 month
49%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on Acutaas Chemicals in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On Acutaas Chemicals
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS's model gives Acutaas Chemicals a 49% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between ₹3,070 and ₹3,625; in 9 out of 10, between ₹2,650 and ₹4,199. Estimated annual volatility is 49%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- ₹266B
- Market cap (USD)
- $2.8B
- P/E ratio
- 119.1
- Dividend yield
- 0.18%
- 52-week high
- ₹3,900
- 52-week low
- ₹1,570
- Revenue (12 months)
- ₹10.1B
- Operating margin
- 22.1%
- Net margin
- 45.2%
What this means
ATLAS does not publish a fair value for AMIORG.NSE right now, but it does show its odds of rising: close to a coin flip.
Over the last 52 weeks AMIORG.NSE has traded between ₹1,570 and ₹3,900. Today it is 14.1% below that high and 113% above its low.
On the business: net margin is 45.2%; it trades at 119.1 times earnings.
About the company
Acutaas Chemicals Limited is a specialty chemicals and pharmaceutical intermediates company headquartered in Surat, India.
Want to see everything about Acutaas Chemicals?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What does Acutaas Chemicals do?
Acutaas Chemicals Limited is a specialty chemicals and pharmaceutical intermediates company headquartered in Surat, India.
What is the chance AMIORG.NSE goes up next month?
49%: close to a coin flip. In half of the simulated outcomes, AMIORG.NSE ends the month between ₹3,070 and ₹3,625.
How big is Acutaas Chemicals and what is its P/E ratio?
Acutaas Chemicals's market capitalization is ₹266B. Its price-to-earnings (P/E) ratio is 119.1: you pay ₹119.1 for each ₹1.00 of yearly earnings.
Does Acutaas Chemicals pay a dividend?
Yes. AMIORG.NSE's current dividend yield is 0.18% at today's price (₹3,349).
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer